Skip to main content
OpenTrials

Clinical trial condition

Hodgkin Disease

Explore clinical trials studying Hodgkin Disease. Study availability and eligibility vary by location and protocol.

958 public trials 98 recruiting studies
Refine in advanced search Browse all conditions

Hodgkin Disease trial results

Recruiting

Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy

NCT05977673

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia Alessandria, IT, Italy
  • Divisione di Oncologia e dei Tumori immuto-correlati, Centro Di Riferimento Oncologico Di Aviano Aviano, Italy
  • Istituto di Ematologia L. e A. Seràgnoli, AOU Policlinico S. Orsola-Malpighi Bologna, Italy
  • SC Ematologia, Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia Brescia, Italy
View Trial Details
Recruiting

CD45BE-HSPC + CART-45 Cells

NCT07451054

Conditions
B-Cell Non-Hodgkin Lymphoma (NHL), Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

NCT03618550

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
Locations
  • City of Hope Cancer Center (Data Collection Only) Duarte, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University of Miami Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
View Trial Details
Recruiting

Personalized NK Cell Therapy in CBT

NCT02727803

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

NCT07020533

Conditions
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +38 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions